AZB, Khaitan & Co act on Rubicon Research ₹1,377.5 crore IPO

Rubicon Research Limited has raised ₹1,377.5 from an initial public offerring comprising a fresh issue and an offer for sale by General Atlantic Singapore RR Pte. Ltd., the promoter selling shareholder.

AZB & Partners advised Rubicon Research on this IPO, according to the DRHP.

Khaitan & Co advised the Book Running Lead Managers i.e., Axis Capital Limited, IIFL Capital Services Limited, JM Financial Limited and SBI Capital Markets Limited, on this IPO.

The transaction team consisted of Subhayu Sen (Partner), Ayush Mohata (Partner), Aparna Bagree (Partner), Johann Valladares (Senior Associate), Associates Aayush Virani, Avantika Tanwar, Mehar Sharma.

Rubicon Research is a pharmaceutical formulations company based in Mumbai that specializes in developing, manufacturing, and marketing branded specialty products for pharmaceutical companies.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.